Minimum alveolar anesthetic concentration of volatile anesthetics in normal and cardiomyopathic hamsters

Anesthesia and Analgesia

Volumn 88, Issue 3, 1999, Pages 489-493

  Vivien, Benoît ^a,b   Langeren, Olivier ^a   Coriat, Pierre ^a   Riou, Bruno ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; SEVOFLURANE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; TISSUE DISTRIBUTION;

EID: 0032975108     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199903000-00004     Document Type: Article

References (33)

1. Quasha AL, Eger EI II, Tinker JH. Determination and applications of MAC. Anesthesiology 1980,3:315-34.
2. Vitez TS, White PF, Eger El II. Effects of hypothermia on halothane MAC and isoflurane MAC in the rat. Anesthesiology 1974;41:80-1.
3. Stevens WC, Dolan WM, Gibbons RT, et al. Minimum alveolar concentration (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975;42: 197-200.
4. Munson ES, Hoffman JC, Eger El II. Use of cyclopropane to test generality of anesthetics requirement in the elderly. Anesth Analg 1984;63:998-1000.
5. Gin T, Chan MTV. Decreased minimum alveolar concentration of isoflurane in pregnant humans. Anesthesiology 1994;81: 829-32.
6. Munson ES, Hoffman JC, DiFazio CA. The effects of acute hypothyroidism and hyperthyroidism on cyclopropane requirement (MAC) in rats. Anesthesiology 1968;29:1094-8.
7. Brian JE, Bogan L, Kennedy RH, Seifen E. The impact of streptozotocin-induced diabetes on the minimum alveolar anesthetic concentration (MAC) of inhaled anesthetics in the rat. Anesth Analg 1993;77:342-5.
8. Gill R, Martin C, McKinnon T, et al. Sepsis reduces isoflurane MAC in a normotensive animal model of sepsis. Can J Anaesth 1995;42:631-5.
9. Riou B, Viars P, Lecarpentier Y. Effects of ketamine on the cardiac papillary muscle of normal hamsters and those with cardiomyopathy. Anesthesiology 1990;73:910-8.
10. Riou B, Lecarpentier Y, Viars P. Effects of etomidate on the cardiac papillary muscle of normal hamsters and those with cardiomyopathy. Anesthesiology 1993;78:83-90.
11. Vivien B, Hanouz JL, Gueugniaud PY, et al. Myocardial effects of halothane and isoflurane in hamsters with hypertrophie cardiomyopathy. Anesthesiology 1997;87:1406-16.
12. White PF, Johnston RR, Eger El II. Determination of anesthetic requirement in rats. Anesthesiology 1974;40:52-7.
13. Mazze RI, Rice SA, Baden JM. Halothane, isoflurane, and enflurane MAC in pregnant and nonpregnant female and male mice and rats. Anesthesiology 1985;62:339-41.
14. Seifen AB, Kennedy RH, Bray JP, Seifen E. Estimation of minimum alveolar concentration (MAC) for halothane, enflurane and isoflurane in spontaneously breathing guinea pigs. Lab Anim Sei 1989;39:579-81.
15. Russel GB, Graybeal JM. Differences in anesthetic potency between Sprague-Dawley and Long-Evans rats for isoflurane but not nitrous oxide. Pharmacology 1995;50:162-7.
16. Eger El II, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965;26:756-63.
17. Munson ES, Martucci RW, Smith RE. Circadian variations in anesthetic requirement and toxicity in rats. Anesthesiology 1970;32:507-14.
18. Cook TL, Beppu WJ, Hitt BA, et al. Renal effects of sevoflurane in Fischer 344 rats: an in vivo and in vitro comparison with methoxyflurane. Anesthesiology 1975;43:70-7.
19. Taheri S, Halsey MJ, Liu J, et al. What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991,72:627-34.
20. Deleted in proof.
21. Deleted in proof.
22. Stanski DR. Monitoring depth of anesthesia. In: Miller RD, ed. Anesthesia. 4th ed. New York: Churchill Livingstone, 1994: 1127-259.
23. Loss GE, Seifen E, Kennedy RH, Seifen AB. Aging: effects on minimum alveolar concentration (MAC) for halothane in Fischer-344 rats. Anesth Analg 1989;68:359-62.
24. Eisele }H, Eger El II, Muallem M. Narcotic properties of carbon dioxide in the dog. Anesthesiology 1967;28:856-65.
25. Bajusz E. Hereditary cardiomyopathy: a new disease model. Am Heart J 1969;77:686-96.
26. Strobeck JE, Factor SM, Bhan A, et al. Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural features. Ann N Y Acad Sei 1979;317: 59-88.
27. Ottenweller JE, Tapp WN, Chen TS, Natelson BH. Cardiovascular aging in Syrian hamsters: similarities between normal aging and disease. Exp Aging Res 1987;13:73-84.
28. Wagner JA, Weisman HF, Snowman AM, et al. Alterations in calcium antagonist receptors and sodium-calcium exchange in cardiomyopathic hamster tissues. Circ Res 1989;65:205-14.
29. 2+-ATPase. Life Sci 1996;59:269-75.
30. Kuo TH, Tsang W, Wang KKW, Carlock L. Simultaneous reduction of the sarcolemmal and SR calcium ATPase activities and gene expression in cardiomyopathic hamster. Biochim Biophys Acta 1992;1138:343-9.
31. Kemmotsu O, Hashimoto Y, Shimosato S. Inotropic effects of isoflurane on mechanics of contraction in isolated cat papillary muscles from normal and failing hearts. Anesthesiology 1973; 39:470-7.
32. Lowenstein E, Foëx P, Francis CM, et al. Regional ischemic ventricular dysfunction in myocardium supplied by a narrowed coronary artery with increasing halothane concentration in the dog. Anesthesiology 1981;55:349-59.
33. Kissin I, Thomson CT, Smith LR. Effects of halothane on contractile function of ischemic myocardium. J Cardiovasc Pharmacol 1983;5:438-42.